The two-day event provided attendees with early access to build with beta products including Agent Studio ... Bristol Myers Squibb today announced that the Committee for Medicinal Products for Human ...
at 07:00 Bristol Myers Squibb Receives Positive CHMP Opinion for Repotrectinib for the Treatment of Advanced ROS1-Positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback